In addition, evaluation of S100P expression can be combined with EUS-FNA quantitative analysis to improve the accuracy of diagnosis of PC and nontumor lesions (89–91) or be applied in fine-needle aspiration biopsy (FNAB) specimens prepared in cell blocks and smears to test for PDAC (92, 93). Here, S100P is linked to pachyonychia congenita.